Italia markets closed

FTSE MIB
34.657,35
+318,03(+0,93%)
Dow Jones
39.473,05
+85,29(+0,22%)
Nasdaq
16.328,37
-17,89(-0,11%)
Nikkei 225
38.229,11
+155,13(+0,41%)
Petrolio
78,34
-0,92(-1,16%)
Bitcoin EUR
56.230,89
-1.379,72(-2,39%)

RTX Corporation (0R2N.IL)

IOB - IOB Prezzo differito. Valuta in USD.

Aggiungi a watchlist

105,45

+0,44

(+0,42%)

Alla chiusura: 07:08PM BST

Capitalizzazione	153,484B
Beta (5 anni mensile)	0,73
Rapporto PE (ttm)	27,97
EPS (ttm)	3,77
Prossima data utili	23 lug 2024 - 29 lug 2024
Rendimento e dividendo (futuro)	2,36 (3,20%)
Data ex dividendo	16 nov 2023
Stima target 1A	N/D

Tutte

GlobeNewswire
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed